| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |